Physician profile
Steven C Jacoby
NPI 1619977667
$1,631.36
in general payments reported to CMS, 2019-2025
25 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $544 · 2020: $191 · 2021: $354 · 2022: $390 · 2023: $152.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $152.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $151.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $286.12 | 2019-2022 | |
| Portola Pharmaceuticals, LLC | $254.04 | 2019 | |
| La Jolla Pharmaceutical Company | $122.39 | 2023 | Giapreza |
| Mylan Specialty L.P. | $106.68 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $98.56 | 2019-2023 | Spiriva Respimat, Stiolto Respimat |
| Astrazeneca Pharmaceuticals Lp | $93.88 | 2019-2022 | |
| Insmed, INC. | $88.40 | 2020-2022 | |
| Pulmonx Corporation | $88.00 | 2019-2022 | |
| United Therapeutics Corporation | $68.33 | 2021-2022 | |
| Genentech USA, INC. | $48.78 | 2019 | |
| Advanced Respiratory, INC | $47.39 | 2021 | |
| Harmony Biosciences LLC | $43.93 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $35.37 | 2021-2023 | Dupixent |
| Genzyme Corporation | $34.83 | 2021 | |
| Electromed, INC. | $33.64 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Grifols USA, LLC | $31.89 | 2022 | |
| Covis Pharma Gmbh | $30.44 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $26.09 | 2020 | |
| Philips North America LLC | $15.00 | 2022 | |
| Mallinckrodt Hospital Products INC. | $14.82 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.32 | 2022 | |
| Pfizer INC. | $14.12 | 2022 | |
| Baxter Healthcare | $12.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $11.31 | 2019 | |
| Circassia INC. | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Jacoby listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.